Stay updated with breaking news from Satellos Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Satellos expects to begin first-in-human clinical trials mid-year for SAT-3247, an oral small molecule drug candidate in development as a novel regenerative medicine approach to treating DMD ...
Satellos Bioscience Inc. announced the formation of a Clinical Advisory Board comprised of distinguished clinical research leaders and experts in drug development in genetic muscle disorders,...
Satellos Bioscience Inc. , a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders, announced today that it has been...
Mining Sector Surges and Technology Issuers Bounce Back in TSX Venture Exchange's 2024 Venture 50 Ranking
Satellos Bioscience Inc. , a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders, today announced a late-breaking...